NAD⁺ precursors vs Urolithin A
Both are sold for cellular energy, but only one has placebo-controlled trials measuring something a person might feel. NAD+ precursors move a biomarker; urolithin A moved muscle endurance.
Short answer
Both are supplements with some human trials behind them, so what separates NAD⁺ precursors and urolithin A is the goal. For a reader focused on cellular energy and anti-aging, NAD⁺ precursors are the relevant choice; urolithin A is marketed for mitochondrial health, muscle and anti-aging.
NAD⁺ precursors
NR / NMN
Oral NR/NMN reliably raise blood NAD⁺ in RCTs — but whether that translates into anti-aging outcomes is still open.
Full NAD⁺ precursors evidence reviewUrolithin A
Mitopure
Strong RCT base for a supplement — reproducibly improves muscle endurance and mitochondrial biomarkers, but primary strength endpoints repeatedly missed.
Full Urolithin A evidence reviewNAD⁺ precursors vs Urolithin A: head to head
- FDA status / approved use
NAD⁺ precursors
Marketed as longevity supplementsUrolithin A
Sold as a longevity supplement- Marketed for
NAD⁺ precursors
Cellular energy, anti-agingUrolithin A
Mitochondrial health, muscle, anti-aging- Outcome areas
NAD⁺ precursors
Mitochondrial / cellular energy; Longevity / lifespanUrolithin A
Mitochondrial / cellular energy; Muscle / strength / lean mass; Exercise performance / endurance; Longevity / lifespan- Evidence grade
NAD⁺ precursors
Clinical dataUrolithin A
Clinical data- How it works
NAD⁺ precursors
Precursors absorbed and converted into NAD+, a molecule that declines with ageUrolithin A
Triggers mitophagy, the clearing of damaged mitochondria- Route and dosing
NAD⁺ precursors
Oral supplementUrolithin A
Daily supplement, up to 1,000 mg per day in trials- Headline human result
NAD⁺ precursors
Raise blood NAD+ in human trials, but no human trial shows they extend healthspan, prevent disease or slow agingUrolithin A
About 12% strength gain as a secondary outcome; primary peak-power endpoint missed in a 2022 RCT of middle-aged adults- Strongest evidence
NAD⁺ precursors
NR PK RCT, Nat Commun 2016NAD⁺ precursors evidence reviewPubMed 27721479Urolithin A
First-in-human, Nat Metab 2019Urolithin A evidence reviewPubMed 32694802- Key safety signal
NAD⁺ precursors
Well tolerated in short-term trials; no long-term safety dataUrolithin A
Safe and well tolerated up to 1,000 mg per day for four months- How it is obtained
NAD⁺ precursors
Over the counter as a dietary supplementUrolithin A
Over the counter as a dietary supplement
| NAD⁺ precursors | Urolithin A | |
|---|---|---|
| FDA status / approved use | Marketed as longevity supplements | Sold as a longevity supplement |
| Marketed for | Cellular energy, anti-aging | Mitochondrial health, muscle, anti-aging |
| Outcome areas | Mitochondrial / cellular energy; Longevity / lifespan | Mitochondrial / cellular energy; Muscle / strength / lean mass; Exercise performance / endurance; Longevity / lifespan |
| Evidence grade | Clinical data | Clinical data |
| How it works | Precursors absorbed and converted into NAD+, a molecule that declines with age | Triggers mitophagy, the clearing of damaged mitochondria |
| Route and dosing | Oral supplement | Daily supplement, up to 1,000 mg per day in trials |
| Headline human result | Raise blood NAD+ in human trials, but no human trial shows they extend healthspan, prevent disease or slow aging | About 12% strength gain as a secondary outcome; primary peak-power endpoint missed in a 2022 RCT of middle-aged adults |
| Strongest evidence | NR PK RCT, Nat Commun 2016NAD⁺ precursors evidence reviewPubMed 27721479 | First-in-human, Nat Metab 2019Urolithin A evidence reviewPubMed 32694802 |
| Key safety signal | Well tolerated in short-term trials; no long-term safety data | Safe and well tolerated up to 1,000 mg per day for four months |
| How it is obtained | Over the counter as a dietary supplement | Over the counter as a dietary supplement |
marks a row where the two differ. “Not established” marks a cell the available evidence does not answer. Evidence grades come from our evidence matrix, which grades each molecule on the human data for the use it is marketed for.
- Clinical data:
- Tested in humans — but investigational, discontinued, or proven only on a surrogate marker (not the marketed outcome).
Our verdict
Urolithin A has the stronger human record: a first-in-human safety study plus multiple placebo-controlled RCTs that reproducibly improved muscle endurance and mitochondrial biomarkers, though the headline strength and power primary endpoints missed significance and the main muscle trials were sponsored by the maker of Mitopure. NR and NMN are well established as bioavailable and reliably raise blood NAD+, but that is a biomarker rather than an outcome, and no trial shows they slow aging or prevent disease. Both are well tolerated, they have not been compared head to head, and neither is proven to extend healthspan.
NAD⁺ precursors fits if
Someone who wants the most-studied way to raise NAD+ itself and is comfortable betting on a plausible mechanism with a measured biomarker rather than a demonstrated benefit.
Urolithin A fits if
Someone who wants the deepest RCT record in the longevity aisle and would count a modest, replicated gain in muscle endurance and mitochondrial markers as a real win.
NAD⁺ precursors vs Urolithin A: common questions
- Is either NAD⁺ precursors or urolithin A FDA-approved?
- No. NAD⁺ precursors are marketed as longevity supplements. Urolithin A is sold as a longevity supplement.
- Which has stronger human evidence, NAD⁺ precursors or urolithin A?
- Neither clearly. Both have human clinical data. The key source for NAD⁺ precursors is NR PK RCT, Nat Commun 2016; for urolithin A, it is first-in-human, Nat Metab 2019.
- What are the main safety concerns with NAD⁺ precursors and urolithin A?
- NAD⁺ precursors are well tolerated in short-term trials; no long-term safety data. Urolithin A is safe and well tolerated up to 1,000 mg per day for four months.
Key studies behind each
NAD⁺ precursors
- Trammell SA, Schmidt MS, Weidemann BJ, et al. (2016). Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat Commun. PubMed 27721479
- Martens CR, Denman BA, Mazzo MR, et al. (2018). Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. PubMed 29599478
- Yoshino M, Yoshino J, Kayser BD, et al. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. PubMed 33888596
- Liao B, Zhao Y, Wang D, et al. (2021). Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study. J Int Soc Sports Nutr. PubMed 34238308
Urolithin A
- Ryu D, Mouchiroud L, Andreux PA, et al. (2016). Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents. Nat Med. PubMed 27400265
- Andreux PA, Blanco-Bose W, Ryu D, et al. (2019). The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nat Metab. PubMed 32694802
- Singh A, D'Amico D, Andreux PA, et al. (2022). Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults. Cell Rep Med. PubMed 35584623
- Liu S, D'Amico D, Shankland E, et al. (2022). Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial. JAMA Netw Open. PubMed 35050355
The full evidence reviews
- NAD+ precursors (NR and NMN): what the human trials actually show
They raise NAD+ and look safe short-term, but human evidence is surrogate-marker level, and no trial shows they extend healthspan.
Updated October 2026
- Urolithin A (Mitopure): real trials, modest results
A mitophagy-inducing postbiotic with unusually strong RCT evidence for a supplement — that reproducibly improves muscle endurance and biomarkers while repeatedly missing its primary strength endpoints.
Updated August 2026
Where to get it
Where to get NAD⁺ therapy
Telehealth services offering NAD⁺ as oral precursors, prescription injections, or clinic IV drips. Formats and pricing vary — confirm current NAD⁺ (NR & NMN) options with the provider.
Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. Partners are listed first; a commission never changes what we write about a provider. How we make money.
- Oak LongevityPartner
Low-cost telehealth NAD⁺ within a broader longevity stack
- HealthRXPartner
NAD⁺ alongside sermorelin and GLP-1 care from one telehealth pharmacy
Bodybuilding Health+PartnerNAD⁺ from Bodybuilding.com's telehealth program
Provider reviews we publish: System LabsCoreAge RxEmbody NAD+DudeMedsCareBareRX10rx